These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28802891)

  • 61. Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome.
    Trimech M; Letourneau A; Missiaglia E; De Prijck B; Nagy-Hulliger M; Somja J; Vivario M; Gaulard P; Lambert F; Bisig B; de Leval L
    Am J Surg Pathol; 2021 Jun; 45(6):773-786. PubMed ID: 33739791
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies.
    Xu W; Yang S; Tam CS; Seymour JF; Zhou K; Opat S; Qiu L; Sun M; Wang T; Trotman J; Pan L; Gao S; Zhou J; Zhou D; Zhu J; Song Y; Hu J; Feng R; Huang H; Su D; Shi M; Li J
    Adv Ther; 2022 Sep; 39(9):4250-4265. PubMed ID: 35900694
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Optimal management of the young patient CLL patient.
    Allan JN; Furman RR
    Best Pract Res Clin Haematol; 2018 Mar; 31(1):73-82. PubMed ID: 29452669
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Disparate survival outcomes after front-line chemoimmunotherapy in older patients with follicular, nodal marginal zone and small lymphocytic lymphoma.
    Olszewski AJ; Shafqat H; Ali S
    Leuk Lymphoma; 2015 Apr; 56(4):942-50. PubMed ID: 24956144
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Improving treatment for patients with chronic lymphocytic leukemia.
    Shanafelt TD
    Hematology; 2012 Apr; 17 Suppl 1():S133-6. PubMed ID: 22507801
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies.
    Rainone M; Siddiqi T
    Curr Hematol Malig Rep; 2022 Feb; 17(1):39-45. PubMed ID: 35028825
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Upper aerodigestive tract cancer in patients with chronic lymphocytic leukemia: incidence, stage, and outcome.
    Pagedar NA; Halfdanarson TR; Karnell LH; Hoffman HT; Funk GF
    Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1171-5. PubMed ID: 23247237
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century.
    Pulte D; Castro FA; Jansen L; Luttmann S; Holleczek B; Nennecke A; Ressing M; Katalinic A; Brenner H;
    J Hematol Oncol; 2016 Mar; 9():28. PubMed ID: 27000264
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG).
    Puła B; Budziszewska BK; Rybka J; Gil L; Subocz E; Długosz-Danecka M; Zawirska D; Waszczuk-Gajda A; Iskierka-Jażdżewska E; Kopacz A; Szymczyk A; Czyż J; Lech-Marańda E; Warzocha K; Jamroziak K
    Anticancer Res; 2018 May; 38(5):3025-3030. PubMed ID: 29715135
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Most morphologic features in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not reliably predict underlying FISH genetics or immunoglobulin heavy chain variable region somatic mutational status.
    Garcia CF; Hunt KE; Kang H; Babb A; Gale JM; Vasef MA; Reichard KK
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):119-27. PubMed ID: 19826250
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment Patterns, Healthcare Resource Utilization, and Costs of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the US.
    Yang X; Zanardo E; Lejeune D; De Nigris E; Sarpong E; Farooqui M; Laliberté F
    Oncologist; 2024 Mar; 29(3):e360-e371. PubMed ID: 38280190
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societé Française de Greffe de Moelle et Therapie Cellulaire.
    Xavier E; Cornillon J; Ruggeri A; Chevallier P; Cornelissen JJ; Andersen NS; Maillard N; Nguyen S; Blaise D; Deconinck E; Veelken H; Milpied N; Van Gelder M; Peffault de Latour R; Gluckman E; Kröger N; Schetelig J; Rocha V
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1515-23. PubMed ID: 25958294
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Granulomatous interstitial nephritis secondary to chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Nasr SH; Shanafelt TD; Hanson CA; Fidler ME; Cornell LD; Sethi S; Chaffee KG; Morris J; Leung N
    Ann Diagn Pathol; 2015 Jun; 19(3):130-6. PubMed ID: 25795422
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Amador-Ortiz C; Goolsby CL; Peterson LC; Wolniak KL; McLaughlin JL; Gao J; Chen YH
    Am J Clin Pathol; 2015 Feb; 143(2):214-22. PubMed ID: 25596247
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Lei MM; Sorial MN; Lou U; Yu M; Medrano A; Ford J; Nemec RA; Abramson JS; Soumerai JD
    Leuk Lymphoma; 2024 May; 65(5):653-659. PubMed ID: 38293753
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evolution in the management of chronic lymphocytic leukemia in Japan: should MRD negativity be the goal?
    Suzumiya J; Takizawa J
    Int J Hematol; 2020 May; 111(5):642-656. PubMed ID: 32253666
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Aoun P; Blair HE; Smith LM; Dave BJ; Lynch J; Weisenburger DD; Pavletic SZ; Sanger WG
    Leuk Lymphoma; 2004 Aug; 45(8):1595-603. PubMed ID: 15370211
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Low-dose fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term results of project Q-lite by the Czech CLL Study Group.
    Smolej L; Brychtová Y; Cmunt E; Doubek M; Špaček M; Belada D; Šimkovič M; Stejskal L; Zygulová I; Urbanová R; Brejcha M; Zuchnická J; Móciková H; Kozák T;
    Br J Haematol; 2021 May; 193(4):769-778. PubMed ID: 33618437
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA.
    Ailawadhi S; Ravelo A; Ng CD; Shah B; Lamarre N; Wang R; Eakle K; Biondo JM
    J Comp Eff Res; 2024 Feb; 13(2):e230119. PubMed ID: 38294335
    [No Abstract]   [Full Text] [Related]  

  • 80. Chronic lymphocytic leukaemia/small lymphocytic lymphoma treatment with rituximab and high-dose methylprednisolone, revisited.
    Vagos Mata A; Espada E; Alves D; Polo B; Costa MJ; Lopes C; F Lacerda J; Raposo J
    Cancer Med; 2021 Dec; 10(24):8768-8776. PubMed ID: 34783174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.